Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa (Q42549535)

2 November 2017

Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa (English)

1 reference

2 November 2017

0 references

Staphylococcus aureus

1 reference

inferred from title

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

1 reference

Vincent H Tam

1

1 reference

2 November 2017

Samer Kabbara

2

1 reference

2 November 2017

Giao Vo

3

1 reference

2 November 2017

Amy N Schilling

4

1 reference

2 November 2017

Elizabeth A Coyle

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Antimicrobial Agents and Chemotherapy

2 November 2017

1 reference

2 November 2017

50

1 reference

2 November 2017

8

1 reference

2 November 2017

2626-2631

1 reference

Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Pharmacodynamics and dosing of aminoglycosides

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Once-daily aminoglycosides in the treatment of gram-positive endocarditis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Duration and clinical relevance of postantibiotic effect in relation to the dosing interval

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Killing and regrowth of bacteria in vitro: a review.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Single daily dosing of amikacin in an in-vitro model.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Pharmacodynamics of tobramycin in patients with cystic fibrosis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

Modelling time-kill studies to discern the pharmacodynamics of meropenem

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538660

National survey of extended-interval aminoglycoside dosing

16 August 2018

1 reference

12 December 2020

Typing of human and bovine Staphylococcus aureus by RAPD-PCR and ribotyping-PCR

1 reference

12 December 2020

Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives

1 reference

12 December 2020

Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity

1 reference

12 December 2020

Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection

1 reference

12 December 2020

The pharmacodynamics of aminoglycosides

1 reference

12 December 2020

Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.01165-05

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

16870751

1 reference